In this issue:
SGLT-2 inhibitors in HFREF
Precipitants of HF hospitalisation and readmission risk
Effect of dapagliflozin according to baseline systolic BP
Cardiac function and sudden cardiac death in HFPEF
Angiotensin receptor neprilysin inhibition based on HF and reninangiotensin antagonist use
Atrial dysfunction in HFPEF with AF
Loop diuretic prescription and outcomes in older HF patients
Long-term outcomes of ICD
Proteomic signatures of HF in relation to LVEF
Empagliflozin in HF: diuretic and cardiorenal effects
Please login below to download this issue (PDF)